SUN-385 Differential Effects of Abaloparatide and Teriparatide on Hip Cortical Volumetric BMD by DXA-Based 3d Modeling

The osteoanabolic agent abaloparatide (ABL) has been shown to significantly increase total hip BMD over an 18-month period in postmenopausal women with osteoporosis. However, it remains unknown if these gains predominantly occur in the cortical or trabecular compartments of the proximal femur, and h...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Endocr Soc
Hlavní autoři: Winzenrieth, Renaud, Ominsky, Michael S, Wang, Yamei, Humbert, Ludovic, Weiss, Richard J
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2020
Témata:
Bone and Mineral Metabolism
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7209294/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.255
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky